Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
143M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
46.4M
-
Shares change
-
-536K
-
Total reported value, excl. options
-
$319M
-
Value change
-
-$7.88M
-
Number of buys
-
31
-
Number of sells
-
-38
-
Price
-
$6.87
Significant Holders of Dyne Therapeutics, Inc. - Common Stock (DYN) as of Q2 2022
93 filings reported holding DYN - Dyne Therapeutics, Inc. - Common Stock as of Q2 2022.
Dyne Therapeutics, Inc. - Common Stock (DYN) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.4M shares
of 143M outstanding shares and own 32.55% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (8.93M shares), MPM ASSET MANAGEMENT LLC (4.95M shares), Deep Track Capital, LP (3.5M shares), Vida Ventures Advisors, LLC (2.96M shares), CITADEL ADVISORS LLC (2.93M shares), Logos Global Management LP (2.9M shares), RA CAPITAL MANAGEMENT, L.P. (2.81M shares), BlackRock Inc. (2.47M shares), FRANKLIN RESOURCES INC (1.75M shares), and Point72 Asset Management, L.P. (1.37M shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.